InsidersTradesSigma
Browse the full directors' dealings record of STEMLINE THERAPEUTICS INC, a listed issuer based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). The latest transaction was reported on 21 January 2016 (Cession). Among the most active insiders: Gionco David. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
3 of 3 declarations